nicergoline has been researched along with Disease Models, Animal in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Bakulin, DA; Kovalenko, AL; Kurkin, DV; Kuznetsova, EV; Lycheva, NA; Morkovin, EI; Myagkova, IA; Robertus, AI; Shmidt, MV; Tarasov, AS | 1 |
| Chen, L; Fang, L; Wang, C; Zang, G | 1 |
| Civelek, E; Erdogan, E; Gonul, E; Kircelli, A; Onal, MB; Ongoru, O; Solmaz, I; Ugurel, S | 1 |
| Duterte, D; Grosdemouge, C; Le Poncin-Lafitte, M; Rapin, JR | 1 |
| Ishikawa, T; Kawata, K; Maekawa, T; Sakabe, T; Setoyama, K; Takeshita, H; Ueda, T | 1 |
| D'Agata, V; Drago, F; Grassi, M; Lauria, N; Spadaro, F; Valerio, C | 1 |
| Golda, V; Petr, R | 2 |
| Dikova, M; Ganshina, TS; Mirzoyan, RS; Nikolov, R; Nikolova, M; Pukhalskaya, TG; Vedernikov, YP; Volobueva, TI | 1 |
| Blavet, N; Clostre, F; Spinnewyn, B | 1 |
11 other study(ies) available for nicergoline and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
[Study of the effect of Unifuzol on cognitive impairment and damage to the hippocampus and cerebral cortex during course administration to rats with bilateral stenosis of the common carotid arteries, causing chronic circulatory failure].
Topics: Animals; Brain Ischemia; Carotid Artery, Common; Carotid Stenosis; Cognitive Dysfunction; Constriction, Pathologic; Cytidine Diphosphate Choline; Disease Models, Animal; Hippocampus; Male; Nicergoline; Rats; Shock | 2023 |
Ameliorative effect of nicergoline on cognitive function through the PI3K/AKT signaling pathway in mouse models of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cognition; Disease Models, Animal; Hippocampus; Male; Mice; Neurogenesis; Neuroprotective Agents; Nicergoline; Nootropic Agents; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction | 2018 |
The effects of intrathecal nicergoline and nimodipine in cerebral vasospasm: an experimental study in rabbits.
Topics: Adrenergic alpha-Antagonists; Angiography, Digital Subtraction; Animals; Basilar Artery; Calcium Channel Blockers; Disease Models, Animal; Injections, Spinal; Male; Neurologic Examination; Nicergoline; Nimodipine; Rabbits; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2011 |
Simultaneous study of haemodynamic, metabolic and behavioural sequelae in a model of cerebral ischaemia in aged rats: effects of nicergoline.
Topics: Aging; Animals; Avoidance Learning; Behavior, Animal; Brain; Brain Ischemia; Cerebrovascular Circulation; Deoxyglucose; Disease Models, Animal; Ergolines; Hemodynamics; Male; Nicergoline; Rats; Rats, Inbred Strains | 1984 |
[Nicergoline, an ergot alkaloid, improves ischemic brain damage by ameliorating the decreased cerebral blood flow and metabolism in spontaneously hypertensive rats].
Topics: Animals; Body Water; Brain; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Ergot Alkaloids; Glucose; Male; Nicergoline; Rats; Rats, Inbred SHR | 1992 |
Effects of vinburnine on experimental models of learning and memory impairments.
Topics: Amnesia, Retrograde; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Learning Disabilities; Male; Mice; Nicergoline; Pentylenetetrazole; Rats; Rats, Inbred Strains; Scopolamine; Seizures; Vinca Alkaloids; Vincamine | 1990 |
Animal model of anxiety: interaction of nicergoline and scopolamine in the genetically hypertensive rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Disease Models, Animal; Ergolines; Hypertension; Nicergoline; Norepinephrine; Rats; Rats, Inbred Strains; Scopolamine | 1989 |
Effects of nicergoline in experimental models related to pathogenesis of migraine.
Topics: Animals; Basilar Artery; Cats; Cerebrovascular Circulation; Disease Models, Animal; Ergolines; In Vitro Techniques; Male; Migraine Disorders; Muscle Contraction; Muscle, Smooth, Vascular; Nicergoline; Rabbits; Rats; Serotonin; Synaptosomes; Vascular Resistance | 1989 |
[Effects of Ginkgo biloba extract on a cerebral ischemia model in gerbils].
Topics: Animals; Brain; Brain Ischemia; Disease Models, Animal; Drug Evaluation, Preclinical; Gerbillinae; Mitochondria; Nicergoline; Oxygen Consumption; Plant Extracts; Plants, Medicinal; Trees; Vincamine | 1986 |
Animal model of depression: effect of nicotergoline and metergoline.
Topics: Animals; Depression; Disease Models, Animal; Electroshock; Ergolines; Female; Male; Metergoline; Motor Activity; Nicergoline; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1987 |